SCHEMBL7823629

SCHEMBL7823629

[CH2]c1ccc(Nc2cccc3ccccc23)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.71
▸ HSD17B10 Q99714 2/20 0.71
▸ TP53 P04637 1/20 0.71
▸ CYP3A4 P08684 1/20 0.71
▸ HPGD P15428 1/20 0.71
▸ ALOX15 P16050 1/20 0.71
▸ TSHR P16473 1/20 0.71
▸ CDC25B P30305 1/20 0.71
▸ ATM Q13315 1/20 0.71
▸ RAB9A P51151 2/20 0.62
▸ KDM4E B2RXH2 5/20 0.55
▸ MAPT P10636 5/20 0.55
▸ GAA P10253 3/20 0.55
▸ TDP1 Q9NUW8 2/20 0.55
▸ MEN1 O00255 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ GLA P06280 1/20 0.55
▸ RECQL P46063 1/20 0.55
▸ FADS1 O60427 1/20 0.54
▸ CCR4 P51679 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29619354 0.90 HSD17B10 (0.87) ALDH1A1HSD17B10TP53CYP3A4HPGD
SCHEMBL651572 0.90 HSD17B10 (0.87) ALDH1A1HSD17B10TP53CYP3A4HPGD
SCHEMBL29521400 0.84 HSD17B10 (0.77) ALDH1A1HSD17B10TP53CYP3A4HPGD
SCHEMBL29609502 0.84 ALDH1A1 (0.92) ALDH1A1HSD17B10TP53CYP3A4HPGD
SCHEMBL74528 0.84 HSD17B10 (0.77) ALDH1A1HSD17B10TP53CYP3A4HPGD
SCHEMBL4797443 0.84 ALDH1A1 (0.92) ALDH1A1HSD17B10TP53CYP3A4HPGD
SCHEMBL29350230 0.84 ALDH1A1 (1.00) ALDH1A1HSD17B10TP53CYP3A4HPGD
SCHEMBL19796 0.84 ALDH1A1 (1.00) ALDH1A1HSD17B10TP53CYP3A4HPGD
Ammonia Solution, Strong SCHEMBL20918916 0.82 ALDH1A1 (0.96) ALDH1A1HSD17B10TP53CYP3A4HPGD
Diphenylamine SCHEMBL1072941 0.82 ALDH1A1 (0.96) ALDH1A1HSD17B10TP53CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 — — EP disclosed
CN-1066729-C Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-06-06 — — CN disclosed
CN-1060173-C Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 2001-01-03 — — CN disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 — — US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 — — EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 — — US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 — — US disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 — — US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 — — US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 — — US disclosed
CN-1157288-A Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-08-20 — — CN disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 — — US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 — — EP disclosed
CN-1118781-A Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 1996-03-20 — — CN disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 — — EP disclosed
Send feedback